Quarterly report · Q2
2914.TEDINET S100OWUD
Period2022-01-01 → 2022-06-30
Filed2022-08-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Amends S100OTFM.
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.27T | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥685.3bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.32T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.14T | 2021-01-01 → 2021-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥597.2bn | 2021-04-01 → 2021-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥383.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥204.6bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥322.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥162.0bn | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥361.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥186.3bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥472.4bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥314.1bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥157.8bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥264.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥140.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥338.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥225.2bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥111.4bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥265.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥140.4bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥340.2bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥225.9bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥111.9bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.65T | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.54T | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.89T | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.89T | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.75T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.86T | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.60T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.68T | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.81T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥748.7bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥480.7bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥538.8bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥110.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥598.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥174.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥38.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥97.5bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥46.5bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥158.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥353.1bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥212.7bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥148.8 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥78.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥190.76 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥126.92 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥62.78 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥148.74 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥78.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥190.68 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥126.86 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥62.76 | 2021-04-01 → 2021-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 55.3% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.3% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 136
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥7.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥496m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥12.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥416m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥99m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥629.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥629.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥390.3bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥209.0bn |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥684.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥684.8bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥395.6bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥209.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-06-30 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-06-30 | ¥898m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥565m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥19.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥19.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥19.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥10.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥10.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥10.8bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-06-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-06-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥26m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥37.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥37.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥672m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥672m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥472m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥70.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥36.7bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥70.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥36.7bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥469m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.04T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥542.6bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.04T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥542.6bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥149m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥86m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥372.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥372.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥337.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥172.1bn |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥1.14T |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥596.7bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥1.14T |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥596.6bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥149m |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥86m |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥377.7bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥377.7bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥341.9bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥190.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥190.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥172.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,136
| Item | Context | Value | Unit |
|---|---|---|---|
| Adjustment items income IFRS | CurrentQuarterDuration | 4986000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 527000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 943000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 1471000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 349000000 | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items costs IFRS | CurrentQuarterDuration | 1820000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 209000000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 299000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 99000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_ReportableSegmentsMember | 209397000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -4784000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration_ReconcilingItemsMember | -10000000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration | 204604000000 | JPY |
| Finance income IFRS | CurrentQuarterDuration | 4735000000 | JPY |
| Finance costs IFRS | CurrentQuarterDuration | 23054000000 | JPY |
| Profit loss before tax IFRS | CurrentQuarterDuration | 186285000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書（2022年８月８日付け訂正報告書の添付インラインXBRL） | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-07-29 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第38期第２四半期（自 2022年４月１日 至 2022年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)日本たばこ産業株式会社 | |
| Company name in english cover page | FilingDateInstant | JAPAN TOBACCO INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 寺畠 正道 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目１番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０３（６６３６）２９１４（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員 Corporate Communications 担当 福田 浩之 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目１番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０３（６６３６）２９１４（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員 Corporate Communications 担当 福田 浩之 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00492 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 29140 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)日本たばこ産業株式会社 | |
| Filer name in english | FilingDateInstant | JAPAN TOBACCO INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Current period end date | FilingDateInstant | 2022-06-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2022-12-31 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |